Potent activity of nobiletin-rich Citrus reticulata peel extract to facilitate cAMP/PKA/ERK/CREB signaling associated with learning and memory in cultured hippocampal neurons: identification of the substances responsible for the pharmacological action Ichiro KawahataMasaaki YoshidaTohru Yamakuni Translational Neurosciences - Original Article 16 April 2013 Pages: 1397 - 1409
Increases in CSF dopamine in HIV patients are due to the dopamine transporter 10/10-repeat allele which is more frequent in HIV-infected individuals Anne HornCarsten Schellerthe German Competence Network HIV/AIDS Translational Neurosciences - Original Article Open access 06 September 2013 Pages: 1411 - 1419
Gender differences in cholinergic and dopaminergic deficits in Parkinson disease Vikas KotagalRoger L. AlbinNicolaas I. Bohnen Neurology and Preclinical Neurological Studies - Short communication 27 March 2013 Pages: 1421 - 1424
Morphological and chemical analysis of a deep brain stimulation electrode explanted from a dystonic patient Carlo MarrasMichele RizziAngelo Franzini Neurology and Preclinical Neurological Studies - Original Article 06 April 2013 Pages: 1425 - 1431
Headache as a symptom at stroke onset in 4,431 young ischaemic stroke patients. Results from the “stroke in young fabry patients (SIFAP1) study” Peter KroppMartin HolzhausenStroke in Young Fabry Patients (sifap) Investigators Neurology and Preclinical Neurological Studies - Original Article 09 June 2013 Pages: 1433 - 1440
A preliminary method development study to identify potential stroke biomarkers in plasma using multiple chromatographies with nanoLC-ESIMS detection Phanichand KodaliJulio A. Landero-FigueroaOpeolu Adeoye Neurology and Preclinical Neurological Studies - Short communication 13 April 2013 Pages: 1441 - 1445
Atrial fibrillation and stroke prevention: is warfarin still an option? Yes J. David Spence Neurology and Preclinical Neurological Studies - CONy Pro/Con debate 12 December 2012 Pages: 1447 - 1451
Atrial fibrillation and stroke prevention: is warfarin still an option?—No R. Lakshmi Narasimhan RanganathanP. Venkatesh Neurology and Preclinical Neurological Studies - CONy Pro/Con debate 14 December 2012 Pages: 1453 - 1456
Editorial Comments: Is multiple sclerosis a neurodegenerative or inflammatory disease? Amos D. Korczyn Comments Open access 06 September 2013 Pages: 1457 - 1457
Is MS an inflammatory or primary degenerative disease? Jacek Losy Neurology and Preclinical Neurological Studies - CONy Pro/Con debate Open access 06 September 2013 Pages: 1459 - 1462
Multiple sclerosis is primarily a neurodegenerative disease Abhijit Chaudhuri Neurology and Preclinical Neurological Studies - CONy Pro/Con debate 28 August 2013 Pages: 1463 - 1466
Is AD a homogeneous nosologic entity? Yes P. Martinez-Martin Neurology and Preclinical Neurological Studies - CONy Pro/Con debate 05 July 2013 Pages: 1467 - 1473
Is Alzheimer’s disease a homogeneous disease entity? Amos D. Korczyn Neurology and Preclinical Neurological Studies - CONy Pro/Con debate 11 August 2013 Pages: 1475 - 1477
Meta-analysis of APOE ε2/ε3/ε4 polymorphism and cerebral infarction Qian-you WangWen-jing WangLi-zhu Han Neurology and Preclinical Neurological Studies - Review Article 10 April 2013 Pages: 1479 - 1489
Effects of atelocollagen on neural stem cell function and its migrating capacity into brain in psychiatric disease model Toshihiro YoshinagaEri HashimotoToshikazu Saito Psychiatry and Preclinical Psychiatric Studies - Original Article 06 April 2013 Pages: 1491 - 1498
MR and GR functional SNPs may modulate tobacco smoking susceptibility Diego L. RovarisNina R. MotaClaiton H. D. Bau Psychiatry and Preclinical Psychiatric Studies - Original Article 31 March 2013 Pages: 1499 - 1505
Facilitative effects of VNS on the motor threshold: implications for its antidepressive mode of action? Helge H. MüllerUdo ReulbachWolfgang Sperling Psychiatry and Preclinical Psychiatric Studies - Short communication 05 June 2013 Pages: 1507 - 1510